abstract |
The invention relates to selective estrogen receptor modulators (SERMs) and to processes for production thereof, to the use thereof for treatment and/or prophylaxis of disorders, and to the use thereof for production of medicaments for treatment and/or prophylaxis of disorders, more particularly of bleeding disorders, osteoporosis, endometriosis, myomas, hormone-dependent tumors, for hormone replacement therapy and for contraception. |